A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease

Jonathan C Cruz1, Li-Huei Tsai

  • 1Department of Pathology, Howard Hughes Medical Institute, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts, 02115 USA. jonathan_cruz@hms.harvard.edu

Insights

Cyclin-dependent kinase 5 (Cdk5) plays dual roles in the central nervous system, crucial for development but also implicated in neurodegenerative diseases. Deregulated Cdk5 activity contributes to tau pathology and neuronal death, highlighting its role in disease progression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin-dependent kinase 5 (Cdk5) is a key kinase in the mammalian central nervous system.
  • Cdk5's function is context-dependent, regulated by various binding partners.
  • Its precise roles in brain development and disease pathogenesis remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular and cellular mechanisms of Cdk5 in central nervous system development and disease.
  • To explore the dual roles of Cdk5, distinguishing its normal functions from pathological involvement.
  • To investigate the link between deregulated Cdk5 activity, tau pathology, and neurodegeneration.

Main Methods:

  • Utilized advanced animal models exhibiting deregulated Cdk5 activity.
  • Investigated signaling pathways orchestrated by Cdk5 during CNS maturation and maintenance.
  • Examined the role of phosphorylation in Cdk5-mediated neurodegenerative processes.

Main Results:

  • Cdk5 orchestrates critical signaling pathways for proper CNS maturation and maintenance.
  • Aberrant Cdk5 activity is linked to the development of tau pathology.
  • Deregulated Cdk5 activity contributes to neuronal cell death in disease models.

Conclusions:

  • Cdk5 exhibits distinct functions in the central nervous system, essential for normal development but detrimental when dysregulated.
  • Understanding Cdk5 regulation is crucial for developing therapeutic strategies against neurodegenerative diseases.
  • Phosphorylation mediated by Cdk5 is a significant factor in the progression of neurodegenerative conditions.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...